TABLE 1.
General characteristics | Evaluated groups | p-value | ||||
---|---|---|---|---|---|---|
Group I (HIV-leprosy) | Group II (leprosy) | |||||
N | % | N | % | |||
Gender | ||||||
Male | 27 | 67.5 | 72 | 67.3 | Chi-square | |
Female | 13 | 32.5 | 35 | 32.7 | p = 0.8623 | |
Total | 40 | 100 | 107 | 100 | ||
Age Range (years) | ||||||
≤ 15 | 1 | 2.5 | 12 | 11.2 | G test | |
16 to 30 | 10 | 25.0 | 31 | 29.0 | p = 0.0872 | |
31 to 59 | 28 | 70.0 | 55 | 51.4 | ||
≥ 60 | 1 | 2.5 | 9 | 8.4 | ||
Total | 40 | 100 | 107 | 100 | ||
Age (years) | ||||||
Mean ± Standard deviation | 37.8±10.4 | 36.2±16.5 | T test | |||
p = 0.4897 | ||||||
Operational classification | ||||||
Paucibacillary | 28 | 70 | 21 | 19.6 | Relative risk = 3.0 | |
Multibacillary | 12 | 30 | 86 | 80.4 | p < 0.0001 | |
Total | 40 | 100 | 107 | 100 | 95%CI = 2.0 - 4.6 | |
Clinical Classification | ||||||
Pure neural | 0 | 0.0 | 3 | 2.8 | G test | |
Indeterminate | 3 | 7.5 | 4 | 3.7 | p < 0.0001 | |
TT | 7 | 17.5 | 14 | 13.1 | ||
BT | 18 | 45.0 | 11 | 10.3 | ||
BB | 10 | 25.0 | 43 | 40.2 | ||
BL | 2 | 5.0 | 21 | 19.6 | ||
LL | 0 | 0.0 | 11 | 10.3 | ||
Total | 40 | 100 | 107 | 100 |